News
Recent Developments in Migraine and Cluster Headache Treatment
On June 4, 2019, the FDA approved galcanezumab-gnlm (Emgality®) for the treatment of episodic cluster headache in adults. This self-injection treatment was first approved by the FDA in September 2018 for the preventive treatment of migraine in adults
Study on School Start Times Shows High Schoolers with Migraine Lack Adequate Sleep
While later start times did not correlate with fewer headache days per month, teenagers with migraine are still getting ‘nowhere near’ enough sleep
Late-Life Ischemic Stroke Risk Not Associated with Early-Onset Migraine
Previous research on the connection between migraine with aura and stroke risk has been challenged by a new retrospective study of ARIC data
Clinical Pearls on Migraine Prevention
Stephanie J. Nahas, MD, FAHS, MSEd explains how migraine prevention and patient education go hand in hand.
The Traffic Light of Headache
Simplifying Acute Migraine Management for Physicians and Patients Using the Canadian Headache Society Guidelines
Migraine Triggers
Studies presented at #AHS18SF explore the link between 4 commonly believed migraine triggers and the onset of a migraine attack
From the Journal: Why Are Certain Manuscripts Rejected from Headache After Peer Review?
Publishing academic manuscripts in peer-reviewed journals is a very competitive process: Most academic journals accept around 20-30% of manuscript submissions, while more competitive journals such as TheNew England Journal of Medicine only accept around 5% of submissions.
Migraine and Contraceptives
AHS doctors discuss the contraindication of contraceptives for women with migraine with aura
Migraine & Stroke Risk in Women
Hans-Christoph Diener, MD, PhD expands on stroke risks specific to women with migraine with aura.
CGRP-Blocking Antibodies: Q&A With Dr. David Dodick
Emerging treatments, such as calcitonin gene-related peptide (CGRP)-blocking antibodies, hope to put an end to migraine. Dr. David Dodick explains how and why they work.
From The Journal: Direct and Indirect Costs of Migraine
New research provides a contemporary estimate of the true cost of migraine
Tension-type headache found to have significant association with white matter hyperintensities
In January, the British Medical journal published an article by Adelborg and colleagues which showed that patients with migraine are more likely to have cardiovascular disease, venous thromboembolism, atrial fibrillation and atrial flutter.
Long Wait Time for Headache Specialty Care?
Headache is a common reason that patients seek out medical care. It is the fifth most common reason for emergency department (ED) visits and accounts for more than 10 million physician visits annually.